Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
The Journal of Antimicrobial Chemotherapy
|
February 8, 2022
Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa
Aanchal Gupta, David Landman, John Quale
Journal of Medical Microbiology
|
June 27, 2009
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
David Landman, Simona Bratu, John Quale
Microbial Drug Resistance (Larchmont, N.Y.)
|
June 26, 2020
Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City Hospitals
Alejandro Iregui, David Landman, John Quale
American Journal of Infection Control
|
April 1, 2014
Are community environmental surfaces near hospitals reservoirs for gram-negative nosocomial pathogens?
Michael Rose, David Landman, John Quale
Journal of Clinical Microbiology
|
October 4, 2013
Irreproducible and uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes
David Landman, Julius Salamera, John Quale
Antimicrobial Agents and Chemotherapy
|
October 16, 2019
Activity of Meropenem with a Novel Broader-Spectrum β-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City
Alejandro Iregui, Zeb Khan, David Landman, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2006
Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates
John Quale, Simona Bratu, Jyoti Gupta, et al.
Journal of Medical Microbiology
|
May 19, 2007
Role of AmpD, OprF and penicillin-binding proteins in beta-lactam resistance in clinical isolates of Pseudomonas aeruginosa
Simona Bratu, David Landman, Jyoti Gupta, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
February 8, 2020
Activity of Cefiderocol Against <i>Enterobacterales</i>, <i>Pseudomonas aeruginosa</i>, and <i>Acinetobacter baumannii</i> Endemic to Medical Centers in New York City
Alejandro Iregui, Zeb Khan, David Landman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2003
Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City
John Quale, Simona Bratu, David Landman, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
The Journal of Antimicrobial Chemotherapy
|
February 8, 2022
Relationship of TonB-dependent receptors with susceptibility to cefiderocol in clinical isolates of Pseudomonas aeruginosa
Aanchal Gupta, David Landman, John Quale
Journal of Medical Microbiology
|
June 27, 2009
Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae
David Landman, Simona Bratu, John Quale
Microbial Drug Resistance (Larchmont, N.Y.)
|
June 26, 2020
Activity of Omadacycline and Other Tetracyclines Against Contemporary Gram-Negative Pathogens from New York City Hospitals
Alejandro Iregui, David Landman, John Quale
American Journal of Infection Control
|
April 1, 2014
Are community environmental surfaces near hospitals reservoirs for gram-negative nosocomial pathogens?
Michael Rose, David Landman, John Quale
Journal of Clinical Microbiology
|
October 4, 2013
Irreproducible and uninterpretable Polymyxin B MICs for Enterobacter cloacae and Enterobacter aerogenes
David Landman, Julius Salamera, John Quale
Antimicrobial Agents and Chemotherapy
|
October 16, 2019
Activity of Meropenem with a Novel Broader-Spectrum β-Lactamase Inhibitor, WCK 4234, against Gram-Negative Pathogens Endemic to New York City
Alejandro Iregui, Zeb Khan, David Landman, et al.
Antimicrobial Agents and Chemotherapy
|
April 28, 2006
Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates
John Quale, Simona Bratu, Jyoti Gupta, et al.
Journal of Medical Microbiology
|
May 19, 2007
Role of AmpD, OprF and penicillin-binding proteins in beta-lactam resistance in clinical isolates of Pseudomonas aeruginosa
Simona Bratu, David Landman, Jyoti Gupta, et al.
Microbial Drug Resistance (Larchmont, N.Y.)
|
February 8, 2020
Activity of Cefiderocol Against <i>Enterobacterales</i>, <i>Pseudomonas aeruginosa</i>, and <i>Acinetobacter baumannii</i> Endemic to Medical Centers in New York City
Alejandro Iregui, Zeb Khan, David Landman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 12, 2003
Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York City
John Quale, Simona Bratu, David Landman, et al.
Page
of 6